EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Xpert MTB/RIF Ultra Trace Results: Decision Support for the Treatment of Extrapulmonary Tuberculosis in Low TB Burden Countries

Aurélie Guillouzouic, Alice Gaudart, Eve Tessier iD, Karine Risso iD, Farida Hamdad, Corentine Alauzet, Pierre Vaillant, Christelle Koebel, Loïc Kassegne, Rachel Chenouard, Pierre Abgueguen, Cécile Le Brun iD und 4 weitere

Journal of Clinical Medicine · 27.04.2023 · 12 (9) · 3148

DOI: 10.3390/jcm12093148 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 27.04.2023. Verfasst von Aurélie Guillouzouic und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Nantes University Hospital, 44093 Nantes, France. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Extrapulmonary tuberculosis (EPTB) can be difficult to diagnose, especially in severe forms. The Xpert MTB/RIF Ultra test introduced an additional category called trace to reference very small amounts of Mycobacterium tuberculosis complex (MTBC) DNA. The objective of our multicenter study was to evaluate whether the trace result on an extrapulmonary (EP) sample is a sufficient argument to consider diagnosing tuberculosis and starting treatment, even in severe cases.

Methods

A retrospective, multicenter cohort study was conducted from 2018 to 2022. Patients strongly suspected of EPTB with a trace result on an EP specimen were included. Hospital records were reviewed for clinical, treatment, and paraclinical data.

Results

A total of 52 patients were included, with a severe form in 22/52 (42.3%) cases. Culture was positive for MTBC in 33/46 (71.7%) cases. Histological analysis showed granulomas in 36/45 (80.0%) cases. An Ultra trace result with a presumptive diagnosis of TB led to the decision to treat 41/52 (78.8%) patients. All patients were started on first-line anti-TB therapy (median duration of 6.1 months), with a favorable outcome in 31/35 (88.6%) patients. The presence of a small amount of MTBC genome in EPTB is a sufficient argument to treat patients across a large region of France.

Schlagwörter

Stichwörter der Autor:innen

Xpert MTB/RIF Ultra testargument to treatclinician’s confidenceextrapulmonary tuberculosistrace result

Autor:innen und Institutionen

  • Department of Microbiology, Nantes University Hospital, 44093 Nantes, France.
  • Department of Microbiology, Nice University Hospital, 06000 Nice, France.
  • Department of Infectious Diseases, Nice University Hospital, 06000 Nice, France.
  • Department of Microbiology, Nancy University Hospital, 54035 Nancy, France.
  • Pulmonary Department, Nancy University Hospital, 54035 Nancy, France.
  • Department of Microbiology, Strasbourg University Hospital, 67091 Strasbourg, France.

ORCID-Profile: Eve Tessier, Karine Risso, Cécile Le Brun, Pascale Bémer

Zitieren

APA

Guillouzouic, A., Gaudart, A., Tessier, E., Risso, K., Hamdad, F., Alauzet, C., Vaillant, P., Koebel, C., Kassegne, L., Chenouard, R., Abgueguen, P., Le Brun, C., Jamard, S., Lecomte, R., Lefebvre, M., & Bémer, P. (2023). Xpert MTB/RIF Ultra Trace Results: Decision Support for the Treatment of Extrapulmonary Tuberculosis in Low TB Burden Countries. Journal of Clinical Medicine, 12(9), 3148. https://doi.org/10.3390/jcm12093148

Vancouver

Guillouzouic A, Gaudart A, Tessier E, Risso K, Hamdad F, Alauzet C, et al. Xpert MTB/RIF Ultra Trace Results: Decision Support for the Treatment of Extrapulmonary Tuberculosis in Low TB Burden Countries. Journal of Clinical Medicine. 2023;12(9):3148. doi:10.3390/jcm12093148

BibTeX
@article{Guillouzouic2023,
  author = {Guillouzouic, Aurélie and Gaudart, Alice and Tessier, Eve and Risso, Karine and Hamdad, Farida and Alauzet, Corentine and Vaillant, Pierre and Koebel, Christelle and Kassegne, Loïc and Chenouard, Rachel and Abgueguen, Pierre and Le Brun, Cécile and Jamard, Simon and Lecomte, Raphaël and Lefebvre, Maeva and Bémer, Pascale},
  title = {Xpert MTB/RIF Ultra Trace Results: Decision Support for the Treatment of Extrapulmonary Tuberculosis in Low TB Burden Countries},
  journal = {Journal of Clinical Medicine},
  year = {2023},
  volume = {12},
  number = {9},
  pages = {3148},
  doi = {10.3390/jcm12093148}
}
Kostenlos starten →